Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B
- PMID: 11442275
- DOI: 10.1023/a:1011011215418
Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B
Abstract
Purpose: To develop and investigate lecithin based oil-water microemulsions as potential amphotericin B (AmB) delivery systems and to evaluate their in vivo acute toxicity.
Methods: AmB was added to the microemulsion and its location was evaluated by partitioning studies and UV-visible spectrophotometric analysis of the drug. Both, non-lyophilized and reconstituted microemulsions were characterised and assessed for their stability. Single-dose acute toxicity of the AmB microemulsion was studied on male albino Webster-derived CD-1 mice and compared with Fungizone.
Results: The studies performed showed that AmB was intercalated on the oil-water interface of the microemulsion as a complex formed with lecithin molecules. AmB addition did not seem to modify the rheological properties of the original system, but had an effect on its particle size distribution. Lyophilization of the microemulsion led to an oily cake, easily reconstituted and stable at the conditions studied. Single-dose acute toxicity studies proved that the LD50 of AmB microemulsions was of 4 mg kg(-1) of animal weight, compared with 1 mg kg(-1) found for Fungizone.
Conclusions: Lyophilized lecithin based oil-water microemulsions appear to be valuable systems for the delivery of AmB in terms of easy and low-cost manufacturing, stability and safety compared with the formulations already in market.
Similar articles
-
Amphotericin B in oil-water lecithin-based microemulsions: formulation and toxicity evaluation.J Pharm Sci. 2002 Apr;91(4):1178-85. doi: 10.1002/jps.10065. J Pharm Sci. 2002. PMID: 11948556
-
Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.J Antimicrob Chemother. 2003 Jul;52(1):103-9. doi: 10.1093/jac/dkg266. Epub 2003 Jun 12. J Antimicrob Chemother. 2003. PMID: 12805269
-
Amphiphilic association systems for Amphotericin B delivery.Int J Pharm. 2003 Jul 24;260(2):249-60. doi: 10.1016/s0378-5173(03)00270-9. Int J Pharm. 2003. PMID: 12842344
-
Lipid formulation as a drug carrier for drug delivery.Curr Pharm Des. 2002;8(6):467-74. doi: 10.2174/1381612023395871. Curr Pharm Des. 2002. PMID: 12069383 Review.
-
The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.Oncol Nurs Forum. 1998 Jan-Feb;25(1):35-48. Oncol Nurs Forum. 1998. PMID: 9460772 Review.
Cited by
-
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Antimicrob Agents Chemother. 2004 Sep;48(9):3246-52. doi: 10.1128/AAC.48.9.3246-3252.2004. Antimicrob Agents Chemother. 2004. PMID: 15328080 Free PMC article.
-
Freeze-drying revolution: unleashing the potential of lyophilization in advancing drug delivery systems.Drug Deliv Transl Res. 2024 May;14(5):1111-1153. doi: 10.1007/s13346-023-01477-7. Epub 2023 Nov 20. Drug Deliv Transl Res. 2024. PMID: 37985541 Review.
-
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.Int J Nanomedicine. 2014 Feb 14;9:877-90. doi: 10.2147/IJN.S55678. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24627630 Free PMC article.
-
Formulation and evaluation of microemulsion based delivery system for amphotericin B.AAPS PharmSciTech. 2008;9(1):122-8. doi: 10.1208/s12249-007-9022-8. Epub 2008 Jan 18. AAPS PharmSciTech. 2008. PMID: 18446472 Free PMC article.
-
Preparation and evaluation of microemulsion‑based transdermal delivery of Cistanche tubulosa phenylethanoid glycosides.Mol Med Rep. 2017 Mar;15(3):1109-1116. doi: 10.3892/mmr.2017.6147. Epub 2017 Jan 25. Mol Med Rep. 2017. PMID: 28138704 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources